Communiqués Abbott Laboratories Sao Paulo

Actions

ABTT34

BRABTTBDR007

Equipement, fournitures et distribution médicale

Marché Fermé - Sao Paulo 21:51:10 14/09/2026			Varia. 5j.	Varia. 1 janv.
44,20 ^BRL	+1,12 %		-4,64 %	-22,94 %

14/09	Abbott Laboratories versera 385 millions de dollars pour clore le litige sur le lait maternisé	MT
14/09	Un accord à 385 millions de dollars entre la justice et Abbott

Communiqués

09:26	Abbott to pay $385M over infant formula contamination probe	AQ
14/09	Abbott agrees to settlement over closure of largest baby formula plant in the US	AQ
14/09	Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall	PR
31/08	Abbott Laboratories : Late-breaking data for Abbott’s TactiFlex™ Duo Ablation Catheter reveal positive outcomes for treating complex AFib cases	PU
31/08	Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula	PR
27/08	Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke	PR
25/08	Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes	PR
20/08	Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants	PR
17/08	Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare	PR
12/08	Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis	PR
11/08	Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI	PR
28/07	Abbott Laboratories : initiates clinical study to show outcomes for real-world use of TriClip™ in repairing leaky tricuspid heart valve	PU
17/07	Army integrating new handheld device to quickly assess brain injuries	AQ
16/07	Abbott Laboratories : ABT 2026 Q2 Exhibit 99.1 FINAL	PU
16/07	Abbott: Q2 Earnings Snapshot	AQ
16/07	Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance	PR
25/06	Court Considers Whether Growth Claims Were Tall Tales	AQ
25/06	Abbott hosts conference call for second-quarter earnings	PR
24/06	ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing	PR
23/06	New Similac(R) survey finds social media pressure to be 'perfect' is fueling a shift toward authenticity for the next generation of parents	AQ
22/06	New Similac® survey finds social media pressure to be "perfect" is fueling a shift toward authenticity for the next generation of parents	PR
18/06	Big Claims, Little Kids: Recent SDNY Decision Highlights Risks In Advertising	AQ
12/06	Abbott declares 410th consecutive quarterly dividend	PR
08/06	New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers	PR
06/06	New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis	PR